241 related articles for article (PubMed ID: 27002501)
1. Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.
Bartsch SM; Hotez PJ; Hertenstein DL; Diemert DJ; Zapf KM; Bottazzi ME; Bethony JM; Brown ST; Lee BY
Vaccine; 2016 Apr; 34(19):2197-206. PubMed ID: 27002501
[TBL] [Abstract][Full Text] [Related]
2. Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.
Lo NC; Bogoch II; Blackburn BG; Raso G; N'Goran EK; Coulibaly JT; Becker SL; Abrams HB; Utzinger J; Andrews JR
Lancet Glob Health; 2015 Oct; 3(10):e629-38. PubMed ID: 26385302
[TBL] [Abstract][Full Text] [Related]
3. Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison.
Collyer BS; Turner HC; Hollingsworth TD; Keeling MJ
Parasit Vectors; 2019 Oct; 12(1):499. PubMed ID: 31647019
[TBL] [Abstract][Full Text] [Related]
4. What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?
Bartsch SM; Asti L; Cox SN; Durham DP; Randall S; Hotez PJ; Galvani AP; Lee BY
J Infect Dis; 2019 Aug; 220(6):920-931. PubMed ID: 30544164
[TBL] [Abstract][Full Text] [Related]
5. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
[TBL] [Abstract][Full Text] [Related]
6. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines.
Alsallaq RA; Gurarie D; Ndeffo Mbah M; Galvani A; King C
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005544. PubMed ID: 28410369
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
[TBL] [Abstract][Full Text] [Related]
10. The potential economic value of a hookworm vaccine.
Lee BY; Bacon KM; Bailey R; Wiringa AE; Smith KJ
Vaccine; 2011 Feb; 29(6):1201-10. PubMed ID: 21167860
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study.
Christensen H; Trotter CL; Hickman M; Edmunds WJ
BMJ; 2014 Oct; 349():g5725. PubMed ID: 25301037
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
13. Cost and cost-effectiveness analysis of mass drug administration compared to school-based targeted preventive chemotherapy for hookworm control in Dak Lak province, Vietnam.
Caesar Delos Trinos JP; Ng-Nguyen D; Coffeng LE; Dyer CEF; Clarke N; Traub R; Halton K; Wiseman V; Watts C; Nery SV
Lancet Reg Health West Pac; 2023 Dec; 41():100913. PubMed ID: 37860202
[TBL] [Abstract][Full Text] [Related]
14. Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.
Holubar M; Stavroulakis MC; Maldonado Y; Ioannidis JP; Contopoulos-Ioannidis D
PLoS One; 2017; 12(3):e0172414. PubMed ID: 28249046
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus immunization program for the United States: impact of performance determinants of a theoretical vaccine.
Régnier SA
Vaccine; 2013 Sep; 31(40):4347-54. PubMed ID: 23896421
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
[TBL] [Abstract][Full Text] [Related]
17. An economic evaluation of expanding hookworm control strategies to target the whole community.
Turner HC; Truscott JE; Bettis AA; Shuford KV; Dunn JC; Hollingsworth TD; Brooker SJ; Anderson RM
Parasit Vectors; 2015 Nov; 8():570. PubMed ID: 26542226
[TBL] [Abstract][Full Text] [Related]
18. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]